secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyell Immunopharma, Inc. (LYEL)
CIK:        0001806952
Form:       8-K
Filed at:   2022-02-15T23:59:59+00:00
Accession:  0001193125-22-043467
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lyell Immunopharma amends Officer Severance Plan, adds tiered benefits
----------------------------------------------------------------------

- Amended severance plan: Tier I gets pro-rated bonus; Tier II & III get base salary and COBRA outside CIC.
- During CIC Protection Period: Tier I receives target bonus; Tier III vesting acceleration increased to 100% (from 75%).
- 2022 base salaries effective Mar 1: Homans $600k, Hill $504k, Turner $473k.
- 2021 bonuses awarded: Homans $433,836; Klausner $222,007; Hill $346,775; Turner $295,925.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1806952/000119312522043467/0001193125-22-043467-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1806952/000119312522043467/d221882d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-043467

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer